Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 499 entries
View as:

Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR

Phase: N/A Priority: Normal
NCT ID: NCT06297772 Org: User:
Start: 06/01/24 End: 05/01/28 Due: 05/01/29

Efficacy and Safety of Pola-RCHP-X Vs Pola-RCHP in Untreated DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT06803693 Org: User:
Start: 04/01/25 End: 12/31/28 Due: 12/31/29

Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - III

Phase: N/A Priority: Normal
NCT ID: NCT06793774 Org: User:
Start: 07/01/24 End: 12/31/27 Due: 12/31/28

A Combination Study of CAR-T Therapy in r/r B-NHL

Phase: N/A Priority: Normal
NCT ID: NCT05871684 Org: User:
Start: 06/10/23 End: 08/30/24 Due: 08/30/25

Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT05002686 Org: User:
Start: 08/07/21 End: 08/01/24 Due: 08/01/25

The Efficacy of Allo-HSCT in ND HR-CBF-AML

Phase: N/A Priority: Normal
NCT ID: NCT06458244 Org: User:
Start: 09/21/24 End: 02/29/28 Due: 02/28/29

The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT06597539 Org: User:
Start: 11/09/24 End: 07/31/27 Due: 07/31/28

Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04525209 Org: User:
Start: 10/01/20 End: 12/31/22 Due: 12/31/23

MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL

Phase: N/A Priority: Normal
NCT ID: NCT06793189 Org: User:
Start: 01/21/25 End: 12/31/28 Due: 12/31/29

Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE)

Phase: N/A Priority: Normal
NCT ID: NCT05694065 Org: User:
Start: 02/17/23 End: 11/22/24 Due: 11/22/25

Verification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT03363685 Org: User:
Start: 11/01/17 End: 11/01/22 Due: 11/01/23

Airway Segmented Stent Modified With 3D Printing for Malignant Stricture Involving Carina and Distal Bronchi

Phase: N/A Priority: Normal
NCT ID: NCT03890575 Org: User:
Start: 04/01/17 End: 12/31/22 Due: 12/31/23

Pilot Trial of Colchicine for Graft Failure in CABG

Phase: N/A Priority: Normal
NCT ID: NCT06802926 Org: User:
Start: 07/31/25 End: 12/31/27 Due: 12/31/28

Mechanism of Resistance to GNC-038 in Relapsed and Refractory Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05189782 Org: User:
Start: 08/10/22 End: 09/01/24 Due: 09/01/25

PRogression of Atheroma Evaluated by CT Angiography and IntraCoronary Imaging tEchniques

Phase: N/A Priority: Normal
NCT ID: NCT06794684 Org: User:
Start: 01/01/16 End: 05/31/30 Due: 05/31/31

Zanubrutinib, Lenalidomide and Rituximab (ZR2) in Elderly Treatment-naive Patients With Diffuse Large B-cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT04460248 Org: User:
Start: 08/26/20 End: 12/01/25 Due: 12/01/26

CArdioMetabolism and Atherosclerotic PlaqUe progreSsion

Phase: N/A Priority: Normal
NCT ID: NCT05117424 Org: User:
Start: 01/01/17 End: 12/31/25 Due: 12/31/26

Cell Free DNA in Mature B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04088422 Org: User:
Start: 09/28/22 End: 12/31/26 Due: 12/31/27

First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT06621576 Org: User:
Start: 09/18/24 End: 09/30/25 Due: 09/30/26

Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06943690 Org: User:
Start: 05/31/25 End: 06/30/27 Due: 06/30/28

Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02753543 Org: User:
Start: 11/30/15 End: 11/30/19 Due: 11/30/20

Artificial Intelligence in Computed Tomography for Quantifying Lung Changes of Bronchiectasis Patients

Phase: N/A Priority: Normal
NCT ID: NCT05751538 Org: User:
Start: 03/01/23 End: 12/30/23 Due: 12/30/24

Follow Up Study for Treatment of Parkinson's Disease With Subthalamic Deep Brain Stimulation

Phase: N/A Priority: Normal
NCT ID: NCT03230331 Org: User:
Start: 07/24/17 End: 05/01/19 Due: 05/01/20

Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT04842318 Org: User:
Start: 03/01/21 End: 03/01/24 Due: 03/01/25

Effect of Oxycodone on Anxiety State in Painless Abortion

Phase: N/A Priority: Normal
NCT ID: NCT06435949 Org: User:
Start: 07/01/24 End: 06/30/26 Due: 06/30/27